These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 37080929

  • 1. Galleria mellonella as an alternative in vivo model to study implant-associated fungal infections.
    Mannala GK, Rupp M, Walter N, Scholz KJ, Simon M, Riool M, Alt V.
    J Orthop Res; 2023 Nov; 41(11):2547-2559. PubMed ID: 37080929
    [Abstract] [Full Text] [Related]

  • 2. Antifungal activity of amphotericin B and voriconazole against the biofilms and biofilm-dispersed cells of Candida albicans employing a newly developed in vitro pharmacokinetic model.
    El-Azizi M, Farag N, Khardori N.
    Ann Clin Microbiol Antimicrob; 2015 Apr 03; 14():21. PubMed ID: 25885806
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells.
    do Nascimento Dias J, de Souza Silva C, de Araújo AR, Souza JMT, de Holanda Veloso Júnior PH, Cabral WF, da Glória da Silva M, Eaton P, de Souza de Almeida Leite JR, Nicola AM, Albuquerque P, Silva-Pereira I.
    Sci Rep; 2020 Jun 25; 10(1):10327. PubMed ID: 32587287
    [Abstract] [Full Text] [Related]

  • 4. Verapamil inhibits efflux pumps in Candida albicans, exhibits synergism with fluconazole, and increases survival of Galleria mellonella.
    Vega-Chacón Y, de Albuquerque MC, Pavarina AC, Goldman GH, Mima EGO.
    Virulence; 2021 Dec 25; 12(1):231-243. PubMed ID: 33410730
    [Abstract] [Full Text] [Related]

  • 5. The synergistic antifungal effects of gypenosides combined with fluconazole against resistant Candida albicans via inhibiting the drug efflux and biofilm formation.
    Liu Y, Ren H, Wang D, Zhang M, Sun S, Zhao Y.
    Biomed Pharmacother; 2020 Oct 25; 130():110580. PubMed ID: 32745913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antifungal activity of ribavirin used alone or in combination with fluconazole against Candida albicans is mediated by reduced virulence.
    Zhang M, Yan H, Lu M, Wang D, Sun S.
    Int J Antimicrob Agents; 2020 Jan 25; 55(1):105804. PubMed ID: 31605727
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of voriconazole in vitro and in invertebrate model of cryptococcosis.
    de Castro Spadari C, da Silva de Bastiani FWM, Pisani PBB, de Azevedo Melo AS, Ishida K.
    Arch Microbiol; 2020 May 25; 202(4):773-784. PubMed ID: 31832690
    [Abstract] [Full Text] [Related]

  • 9. Synergistic potential of teriflunomide with fluconazole against resistant Candida albicans in vitro and in vivo.
    Li X, Kong B, Sun Y, Sun F, Yang H, Zheng S.
    Front Cell Infect Microbiol; 2023 May 25; 13():1282320. PubMed ID: 38169891
    [Abstract] [Full Text] [Related]

  • 10. Using Galleria mellonella-Candida albicans infection model to evaluate antifungal agents.
    Li DD, Deng L, Hu GH, Zhao LX, Hu DD, Jiang YY, Wang Y.
    Biol Pharm Bull; 2013 May 25; 36(9):1482-7. PubMed ID: 23995660
    [Abstract] [Full Text] [Related]

  • 11. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
    Singh R, Kumari A, Kaur K, Sethi P, Chakrabarti A.
    J Med Microbiol; 2018 Jul 25; 67(7):922-926. PubMed ID: 29767615
    [Abstract] [Full Text] [Related]

  • 12. Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis.
    Jafri H, Ahmad I.
    J Mycol Med; 2020 Apr 25; 30(1):100911. PubMed ID: 32008964
    [Abstract] [Full Text] [Related]

  • 13. Antifungal activity and potential mechanism of Asiatic acid alone and in combination with fluconazole against Candida albicans.
    Wang Y, Lu C, Zhao X, Wang D, Liu Y, Sun S.
    Biomed Pharmacother; 2021 Jul 25; 139():111568. PubMed ID: 33845374
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antifungal activity against planktonic and biofilm Candida albicans in an experimental model of foreign-body infection.
    Maiolo EM, Oliva A, Furustrand Tafin U, Perrotet N, Borens O, Trampuz A.
    J Infect; 2016 Mar 25; 72(3):386-92. PubMed ID: 26723911
    [Abstract] [Full Text] [Related]

  • 17. Antifungal efficacy during Candida krusei infection in non-conventional models correlates with the yeast in vitro susceptibility profile.
    Scorzoni L, de Lucas MP, Mesa-Arango AC, Fusco-Almeida AM, Lozano E, Cuenca-Estrella M, Mendes-Giannini MJ, Zaragoza O.
    PLoS One; 2013 Mar 25; 8(3):e60047. PubMed ID: 23555877
    [Abstract] [Full Text] [Related]

  • 18. Analysis of Biofilm-Related Genes and Antifungal Susceptibility Pattern of Vaginal Candida albicans and Non-Candida albicans Species.
    Mohammadi F, Hemmat N, Bajalan Z, Javadi A.
    Biomed Res Int; 2021 Mar 25; 2021():5598907. PubMed ID: 34136569
    [Abstract] [Full Text] [Related]

  • 19. The effect of Ginkgolide B combined with fluconazole against drug-resistant Candida albicans based on common resistance mechanisms.
    Li Y, Yang J, Li X, Su S, Chen X, Sun S, Li Y.
    Int J Antimicrob Agents; 2020 Aug 25; 56(2):106030. PubMed ID: 32454072
    [Abstract] [Full Text] [Related]

  • 20. In vitro method to study antifungal perfusion in Candida biofilms.
    Samaranayake YH, Ye J, Yau JY, Cheung BP, Samaranayake LP.
    J Clin Microbiol; 2005 Feb 25; 43(2):818-25. PubMed ID: 15695686
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.